| NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs S Hussain, AA Sajini, S Blanco, S Dietmann, P Lombard, Y Sugimoto, ... Cell reports 4 (2), 255-261, 2013 | 518 | 2013 |
| iCLIP: Protein–RNA interactions at nucleotide resolution I Huppertz, J Attig, A D’Ambrogio, LE Easton, CR Sibley, Y Sugimoto, ... Methods 65 (3), 274-287, 2014 | 494 | 2014 |
| Structure of the large ribosomal subunit from human mitochondria A Brown, A Amunts, X Bai, Y Sugimoto, PC Edwards, G Murshudov, ... Science 346 (6210), 718-722, 2014 | 363 | 2014 |
| Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain B Rogelj, LE Easton, GK Bogu, LW Stanton, G Rot, T Curk, B Zupan, ... Scientific reports 2 (1), 1-10, 2012 | 338 | 2012 |
| hiCLIP reveals the in vivo atlas of mRNA secondary structures recognized by Staufen 1 Y Sugimoto, A Vigilante, E Darbo, A Zirra, C Militti, A D’Ambrogio, ... Nature 519 (7544), 491-494, 2015 | 290 | 2015 |
| Analysis of CLIP and iCLIP methods for nucleotide-resolution studies of protein-RNA interactions Y Sugimoto, J König, S Hussain, B Zupan, T Curk, M Frye, J Ule Genome biology 13 (8), 1-13, 2012 | 268 | 2012 |
| A retained intron in the 3′‐UTR of Calm3 mRNA mediates its Staufen2‐ and activity‐dependent localization to neuronal dendrites T Sharangdhar, Y Sugimoto, J Heraud‐Farlow, SM Fernández‐Moya, ... EMBO reports 18 (10), 1762-1774, 2017 | 84 | 2017 |
| USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer JK Nelson, MZ Thin, T Evan, S Howell, M Wu, B Almeida, N Legrave, ... Nature Communications 13 (1), 1-18, 2022 | 51 | 2022 |
| Using hiCLIP to identify RNA duplexes that interact with a specific RNA-binding protein Y Sugimoto, AM Chakrabarti, NM Luscombe, J Ule Nature Protocols 12 (3), 611-637, 2017 | 26 | 2017 |
| Poly (ethylene glycol)-lipid-conjugated antibodies enhance dendritic cell phagocytosis of apoptotic cancer cells U Tomita, S Yamaguchi, Y Sugimoto, S Takamori, T Nagamune Pharmaceuticals 5 (5), 405-416, 2012 | 19 | 2012 |
| Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6 ME Cockman, Y Sugimoto, HB Pegg, N Masson, E Salah, A Tumber, ... Proceedings of the National Academy of Sciences 119 (32), e2201483119, 2022 | 16 | 2022 |
| Isoform-resolved mRNA profiling of ribosome load defines interplay of HIF and mTOR dysregulation in kidney cancer Y Sugimoto, PJ Ratcliffe Nature structural & molecular biology 29 (9), 871-880, 2022 | 13 | 2022 |
| Hif-2α programmes oxygen chemosensitivity in chromaffin cells M Prange-Barczynska, H Jones, Y Sugimoto, X Cheng, J Lima, ... bioRxiv, 2023.07. 14.548982, 2023 | 3 | 2023 |
Jernej UleThe Francis Crick Institute, UK Dementia Research Institute at King's, Institute of ChemistryEmail verificata su crick.ac.uk